Yonhap Infomax NewsMay 21, 2025
Celltrion sees potential for expanded biosimilar prescriptions following US drug price reduction measures, expecting limited impact on its products and positive opportunities for sales activities.
#YonhapInfomax #Celltrion #Biosimilars #DrugPriceReduction #USHealthcare #PrescriptionDrugs #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64175
US Takes Follow-up Measures on Drug Price Cuts - Celltrion Sees 'Opportunity for Expanded Prescriptions'

Celltrion sees potential for expanded biosimilar prescriptions following US drug price reduction measures, expecting limited impact on its products and positive opportunities for sales activities.

Yonhap Infomax
Yonhap Infomax NewsMay 13, 2025
Celltrion sees growth opportunities in US drug price reduction executive order, anticipating market expansion through improved distribution structure and direct price negotiations with government.
#YonhapInfomax #Celltrion #DrugPriceReduction #ExecutiveOrder #Biosimilars #MarketExpansion #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=63004
US Drug Price Reduction Executive Order - Celltrion Sees 'Growth Opportunity'

Celltrion sees growth opportunities in US drug price reduction executive order, anticipating market expansion through improved distribution structure and direct price negotiations with government.

Yonhap Infomax
Yonhap Infomax NewsMay 12, 2025
Trump announces executive order to drastically cut prescription drug prices by 30-80%, aiming for global price parity and U.S. market fairness
#YonhapInfomax #TrumpExecutiveOrder #PrescriptionDrugPrices #PharmaceuticalIndustry #HealthcareReform #DrugPriceReduction #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=62722
Trump - 'Prescription Drug Prices Will Be Reduced by 30-80% Almost Immediately' (Update)

Trump announces executive order to drastically cut prescription drug prices by 30-80%, aiming for global price parity and U.S. market fairness

Yonhap Infomax